These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12199693)

  • 1. Insufficient hydrogen-bond desolvation and prion-related disease.
    Fernández A
    Eur J Biochem; 2002 Sep; 269(17):4165-8. PubMed ID: 12199693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of hydrogen bond desolvation in protein folding.
    Fernández A; Sosnick TR; Colubri A
    J Mol Biol; 2002 Aug; 321(4):659-75. PubMed ID: 12206781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change.
    Kanyo ZF; Pan KM; Williamson RA; Burton DR; Prusiner SB; Fletterick RJ; Cohen FE
    J Mol Biol; 1999 Nov; 293(4):855-63. PubMed ID: 10543972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics.
    Viles JH; Donne D; Kroon G; Prusiner SB; Cohen FE; Dyson HJ; Wright PE
    Biochemistry; 2001 Mar; 40(9):2743-53. PubMed ID: 11258885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomedicine. A view from the top--prion diseases from 10,000 feet.
    Priola SA; Chesebro B; Caughey B
    Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843
    [No Abstract]   [Full Text] [Related]  

  • 6. Spongiform diseases. Waiting for the final experiment.
    Enserink M
    Science; 2005 Dec; 310(5755):1758. PubMed ID: 16357238
    [No Abstract]   [Full Text] [Related]  

  • 7. Desolvation shell of hydrogen bonds in folded proteins, protein complexes and folding pathways.
    Fernández A
    FEBS Lett; 2002 Sep; 527(1-3):166-70. PubMed ID: 12220654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transmembrane form of the prion protein in neurodegenerative disease.
    Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
    Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some implications of the prion paradigm: caveat denaturor.
    Lederberg J
    JAMA; 1999 Oct; 282(14):1332-3. PubMed ID: 10527177
    [No Abstract]   [Full Text] [Related]  

  • 12. Prion diseases and the 'protein only' hypothesis: a theoretical dynamic study.
    Laurent M
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):35-9. PubMed ID: 8761449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scrapie prions: a three-dimensional model of an infectious fragment.
    Huang Z; Prusiner SB; Cohen FE
    Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion diseases and the central dogma of molecular biology.
    Hunter N
    Trends Microbiol; 1999 Jul; 7(7):265-6. PubMed ID: 10390630
    [No Abstract]   [Full Text] [Related]  

  • 16. Chaperone-supervised conversion of prion protein to its protease-resistant form.
    DebBurman SK; Raymond GJ; Caughey B; Lindquist S
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13938-43. PubMed ID: 9391131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-genetic propagation of strain-specific properties of scrapie prion protein.
    Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
    Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
    Kellershohn N; Laurent M
    Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion strains in mammals: Different conformations leading to disease.
    Morales R
    PLoS Pathog; 2017 Jul; 13(7):e1006323. PubMed ID: 28683090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.